Kirchner KA, Kotchen TA, Galla JH, Luke RG (November 1978). "Importance of chloride for acute inhibition of renin by sodium chloride". The American Journal of Physiology. 235 (5): F444–50. doi:10.1152/ajprenal.1978.235.5.F444. PMID31796.
Kim SM, Mizel D, Huang YG, Briggs JP, Schnermann J (May 2006). "Adenosine as a mediator of macula densa-dependent inhibition of renin secretion". American Journal of Physiology. Renal Physiology. 290 (5): F1016–23. doi:10.1152/ajprenal.00367.2005. PMID16303857. S2CID270730.
Schnermann JB, Castrop H (2013). "Function of the Juxtaglomerular Apparatus". In Alpern RJ, Moe OW, Caplan M (eds.). Seldin and Giebisch's the Kidney (Fifth ed.). Academic Press. pp. 757–801. doi:10.1016/B978-0-12-381462-3.00023-9. ISBN978-0-12-381462-3.
Padia SH, Howell NL, Siragy HM, Carey RM (March 2006). "Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat". Hypertension. 47 (3): 537–544. doi:10.1161/01.HYP.0000196950.48596.21. PMID16380540. S2CID37807540.
Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL (November 2004). "The angiotensin IV/AT4 receptor". Cellular and Molecular Life Sciences. 61 (21): 2728–2737. doi:10.1007/s00018-004-4246-1. PMID15549174. S2CID22816307.
Wright JW, Harding JW (2015-01-01). "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease". Journal of Alzheimer's Disease. 45 (4): 985–1000. doi:10.3233/JAD-142814. PMID25649658.
Wright JW, Kawas LH, Harding JW (February 2015). "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases". Progress in Neurobiology. 125: 26–46. doi:10.1016/j.pneurobio.2014.11.004. PMID25455861. S2CID41360989.
Wright JW, Krebs LT, Stobb JW, Harding JW (January 1995). "The angiotensin IV system: functional implications". Frontiers in Neuroendocrinology. 16 (1): 23–52. doi:10.1006/frne.1995.1002. PMID7768321. S2CID20552386.
Gross PM, Wainman DS, Shaver SW, Wall KM, Ferguson AV (March 1990). "Metabolic activation of efferent pathways from the rat area postrema". The American Journal of Physiology. 258 (3 Pt 2): R788-97. doi:10.1152/ajpregu.1990.258.3.R788. PMID2316724.
Kirchner KA, Kotchen TA, Galla JH, Luke RG (November 1978). "Importance of chloride for acute inhibition of renin by sodium chloride". The American Journal of Physiology. 235 (5): F444–50. doi:10.1152/ajprenal.1978.235.5.F444. PMID31796.
Kim SM, Mizel D, Huang YG, Briggs JP, Schnermann J (May 2006). "Adenosine as a mediator of macula densa-dependent inhibition of renin secretion". American Journal of Physiology. Renal Physiology. 290 (5): F1016–23. doi:10.1152/ajprenal.00367.2005. PMID16303857. S2CID270730.
Patel P, Sanghavi D, Morris DL, Kahwaji CI (2023). "Angiotensin II". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID29763087.
Padia SH, Howell NL, Siragy HM, Carey RM (March 2006). "Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat". Hypertension. 47 (3): 537–544. doi:10.1161/01.HYP.0000196950.48596.21. PMID16380540. S2CID37807540.
Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL (November 2004). "The angiotensin IV/AT4 receptor". Cellular and Molecular Life Sciences. 61 (21): 2728–2737. doi:10.1007/s00018-004-4246-1. PMID15549174. S2CID22816307.
Wright JW, Harding JW (2015-01-01). "The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease". Journal of Alzheimer's Disease. 45 (4): 985–1000. doi:10.3233/JAD-142814. PMID25649658.
Wright JW, Kawas LH, Harding JW (February 2015). "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases". Progress in Neurobiology. 125: 26–46. doi:10.1016/j.pneurobio.2014.11.004. PMID25455861. S2CID41360989.
Wright JW, Krebs LT, Stobb JW, Harding JW (January 1995). "The angiotensin IV system: functional implications". Frontiers in Neuroendocrinology. 16 (1): 23–52. doi:10.1006/frne.1995.1002. PMID7768321. S2CID20552386.
Gross PM, Wainman DS, Shaver SW, Wall KM, Ferguson AV (March 1990). "Metabolic activation of efferent pathways from the rat area postrema". The American Journal of Physiology. 258 (3 Pt 2): R788-97. doi:10.1152/ajpregu.1990.258.3.R788. PMID2316724.
ncbi.nlm.nih.gov
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Kim SM, Mizel D, Huang YG, Briggs JP, Schnermann J (May 2006). "Adenosine as a mediator of macula densa-dependent inhibition of renin secretion". American Journal of Physiology. Renal Physiology. 290 (5): F1016–23. doi:10.1152/ajprenal.00367.2005. PMID16303857. S2CID270730.
Padia SH, Howell NL, Siragy HM, Carey RM (March 2006). "Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat". Hypertension. 47 (3): 537–544. doi:10.1161/01.HYP.0000196950.48596.21. PMID16380540. S2CID37807540.
Chai SY, Fernando R, Peck G, Ye SY, Mendelsohn FA, Jenkins TA, Albiston AL (November 2004). "The angiotensin IV/AT4 receptor". Cellular and Molecular Life Sciences. 61 (21): 2728–2737. doi:10.1007/s00018-004-4246-1. PMID15549174. S2CID22816307.
Wright JW, Kawas LH, Harding JW (February 2015). "The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases". Progress in Neurobiology. 125: 26–46. doi:10.1016/j.pneurobio.2014.11.004. PMID25455861. S2CID41360989.
Wright JW, Krebs LT, Stobb JW, Harding JW (January 1995). "The angiotensin IV system: functional implications". Frontiers in Neuroendocrinology. 16 (1): 23–52. doi:10.1006/frne.1995.1002. PMID7768321. S2CID20552386.